{"id":3953,"count":14,"description":"Cump\u0103ra\u021bi medicamente hipolipemiante online \u2014 atorvastatin, rosuvastatin, simvastatin, pitavastatin, ezetimib, fenofibrat \u0219i colestiramin\u0103 \u2014 pentru preven\u021bia cardiovascular\u0103 primar\u0103 \u0219i secundar\u0103.<\/strong> Colesterolul ridicat (LDL-C \u0219i non-HDL-C crescut) este unul dintre principalii factori modificabili care duc la infarct miocardic, accident vascular cerebral ischemic \u0219i boal\u0103 arterial\u0103 periferic\u0103. Ghidurile ESC\/EAS din 2019, AHA\/ACC din 2018 \u0219i cele lipidice ACC\/AHA din 2025 pun accent pe reducerea LDL-C ca interven\u021bie principal\u0103 \u2014 fiecare sc\u0103dere de 1 mmol\/L (~38 mg\/dL) a LDL-C reduce evenimentele cardiovasculare cu 20\u201325%<\/strong> \u00een preven\u021bia primar\u0103, preven\u021bia secundar\u0103, diabet, boal\u0103 renal\u0103 cronic\u0103 \u0219i popula\u021bii post-AVC. Alegerea agentului depinde de LDL-C ini\u021bial, risc de ASCVD, toleran\u021ba la statine, \u00eenc\u0103rc\u0103tura de trigliceride \u0219i statutul de sarcin\u0103.Statine de \u00eenalt\u0103 intensitate<\/strong> (reducere \u226550% LDL-C). Atorvatin<\/a> (atorvastatin 5 mg) \u0219i Thyronorm<\/a> (atorvastatin) acoper\u0103 molecula lipofil\u0103 eliminat\u0103 prin CYP3A4 \u2014 molecula Lipitor, de prim\u0103 inten\u021bie pentru preven\u021bia secundar\u0103 la doze de 40\u201380 mg. Omoloagele rosuvastatinului Crestor<\/a>, Rozucor<\/a>, Rosu HDL<\/a>, \u0219i Rosuline<\/a> ofer\u0103 cea mai mare sc\u0103dere a LDL pe miligram (rosuvastatin 20 mg \u2248 atorvastatin 40 mg) cu cinetic\u0103 hidrofil\u0103 \u0219i interac\u021biune minim\u0103 cu CYP3A4 \u2014 preferate c\u00e2nd pacientul ia inhibitori de CYP3A4 (claritromicin\u0103, diltiazem, antifungice) sau a avut simptome musculare legate de statine la atorvastatin.Statine de intensitate moderat\u0103<\/strong> (reducere 30\u201349% LDL-C) pentru preven\u021bia primar\u0103 sau pacien\u021bi intoleran\u021bi la statine. Paginile simvastatinului Simvatic<\/a>, Simlo 5<\/a>, Sim HDL<\/a>, \u0219i Simvotin<\/a> acoper\u0103 statinul original din anii 1990 (alerta FDA 2011 pentru miopatie limitat\u0103 la 80 mg). Pivasta<\/a> (pitavastatin) este cea mai nou\u0103 molecul\u0103, glucuronidat\u0103 \u00een loc s\u0103 fie metabolizat\u0103 de CYP \u2014 medicamentul de referin\u021b\u0103 pentru pacien\u021bii transplanta\u021bi sub ciclosporin\u0103, unde majoritatea statinelor sunt contraindicate.Op\u021biuni adi\u021bionale \u0219i alternative non-statinice.<\/strong> Ezedoc<\/a> (ezetimibe 10 mg) blocheaz\u0103 absorb\u021bia intestinal\u0103 a colesterolului prin inhibarea NPC1L1 \u2014 adaug\u0103 o sc\u0103dere suplimentar\u0103 de ~24% LDL peste orice statin\u0103 (beneficiu cardiovascular demonstrat \u00een studiul IMPROVE-IT). Lipicard<\/a> (fenofibrat) este agentul PPAR-\u03b1: reduce trigliceridele cu 30\u201350% \u0219i este prima alegere pentru hipertrigliceridemie sever\u0103 (>500 mg\/dL risc de pancreatit\u0103) sau dislipidemie mixt\u0103. Choltran Sachet<\/a> (colestiramin\u0103) este op\u021biunea cu sechestrant de acizi biliari pentru pacien\u021bii cu intoleran\u021b\u0103 la statine, hipercolesterolemie familial\u0103 pediatric\u0103, prurit colestatic \u0219i diaree cu acizi biliari \u2014 neabsorbit, compatibil cu sarcin\u0103.Cum s\u0103 alegi.<\/strong> ASCVD \u22657,5% risc pe 10 ani sau boal\u0103 cardiovascular\u0103 instalat\u0103 \u2192 statin\u0103 de \u00eenalt\u0103 intensitate (atorvastatin 40\u201380 mg sau rosuvastatin 20\u201340 mg). LDL-C \u00eenc\u0103 peste \u021bint\u0103 la doza maxim\u0103 tolerat\u0103 de statin\u0103 \u2192 ad\u0103uga\u021bi ezetimibe. Trigliceride >500 mg\/dL \u2192 fenofibrat prima op\u021biune (prevenire pancreatit\u0103), apoi statin\u0103. Sarcin\u0103 \u2192 colestiramin\u0103 (singurul medicament hipolipemiant compatibil cu sarcina \u2014 statinele sunt absolut contraindicate). Transplant sub ciclosporin\u0103 sau hepatit\u0103 pre-existent\u0103 \u2192 pitavastatin.Toate medicamentele hipolipemiante MedsBase sunt generice aprobate de FDA<\/strong> fabricate de produc\u0103tori certifica\u021bi WHO-GMP<\/strong>. Livrare worldwide. Puncte de loialitate pentru fiecare comand\u0103.\n\nGhidul cump\u0103r\u0103torului 2026:<\/strong> Vede\u021bi lista noastr\u0103 scurt\u0103 Cele mai bune medicamente pentru colesterol 2026<\/a> pentru alegeri clasate, tabel comparativ, note de dozare \u0219i scurt\u0103tur\u0103 de decizie.","link":"https:\/\/medsbase.com\/ro\/high-cholesterol-treatments\/","name":"Tratamente colesterol ridicat","slug":"high-cholesterol-treatments","taxonomy":"product_cat","parent":3223,"meta":[],"menu_order":0,"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat\/3953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"up":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat\/3223"}],"wp:post_type":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product?product_cat=3953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}